EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy

Trude B Wedde iD, Milada S Hagen, Kari M Vatne, Line B Nilsen, Taran P Hellebust, Wolfgang Lilleby

Scandinavian Journal of Urology · 2025

DOI: 10.2340/sju.v60.42165 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Scandinavian Journal of Urology, 2025. Verfasst von Trude B Wedde und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. truwed@ous-hf.no. Hauptthemen laut MEDLINE: Brachytherapy, Prostatic Neoplasms, Cancer Survivors, Sexual Dysfunction, Physiological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer can be treated with external beam radiation therapy (EBRT) alone or combined with high-dose-rate brachytherapy (HDR-BT+), usually with additional hormonal treatment (HT). The aim of this long-term cross-sectional study was to compare patient-reported sexual function, hormonal symptoms and quality of life (QoL) after EBRT-only or HDR-BT+.

Methods

In 2016, minimum 5 years after treatment, men treated with HDR-BT+ (n = 248) or EBRT-only (n = 91) responded to a questionnaire containing the Expanded Prostate Cancer Index Composite (EPIC)-26 and the Short Form-12 (SF-12).

Results

Median age at time of answering the questionnaire was 74 years (range 54–86). The majority in the HDR-BT+ group received HT for ≥ 2 years compared to 1/3rd in the EBRT-only group. In crude analyses, the sexual domain summary score (DSS) was significantly higher in the HDR-BT+ compared to the EBRT-only group (32.3 vs. 24.1). All sexual items were significantly better in the HDR-BT+ group except sexual problem. Significantly less fatigue was seen in the HDR-BT+ group despite longer duration of HT. Physical and mental health were similar in both groups. When adjusted for possible confounders, the differences between treatment groups were no longer statistically significant. Only age was significantly associated with lower sexual scores. Low hormonal DSS was significantly associated with decreased QoL.

Conclusion

Patients treated with HDR-BT+ had not worse long-term sexual function than men treated with EBRT-only. However, this difference disappeared when adjusted for possible confounders. Thus, the interplay of age, HT and fatigue indicates a strong impact on both QoL and sexual function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyProstatic NeoplasmsCancer SurvivorsSexual Dysfunction, PhysiologicalHumansMaleAgedMiddle AgedQuality of LifeAged, 80 and overCross-Sectional StudiesPatient Reported Outcome MeasuresRadiotherapy DosageTime Factors

Autor:innen und Institutionen

  • Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. truwed@ous-hf.no.
  • Department of Public Health, Oslo Metropolitan University of Oslo, Oslo, Norway.
  • Department of Oncology, Akershus University Hospital, Lillestrøm, Norway.
  • Department of Medical Physics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Trude B Wedde

Zitieren

APA

Wedde, T. B., Hagen, M. S., M Vatne, K., Nilsen, L. B., Hellebust, T. P., & Lilleby, W. (2025). Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy. Scandinavian Journal of Urology. https://doi.org/10.2340/sju.v60.42165

Vancouver

Wedde TB, Hagen MS, M Vatne K, Nilsen LB, Hellebust TP, Lilleby W. Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy. Scandinavian Journal of Urology. 2025. doi:10.2340/sju.v60.42165

BibTeX
@article{Wedde2025,
  author = {Wedde, Trude B and Hagen, Milada S and M Vatne, Kari and Nilsen, Line B and Hellebust, Taran P and Lilleby, Wolfgang},
  title = {Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy},
  journal = {Scandinavian Journal of Urology},
  year = {2025},
  doi = {10.2340/sju.v60.42165}
}
Kostenlos starten →